OTCMKTS:HALB

Halberd News Headlines

$0.03
+0.00 (+1.96 %)
(As of 06/18/2021 03:54 PM ET)
Add
Compare
Today's Range
$0.02
$0.03
50-Day Range
$0.03
$0.05
52-Week Range
$0.00
$0.11
Volume2.70 million shs
Average Volume10.44 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Halberd (OTCMKTS HALB) News Headlines Today

SourceHeadline
Halberd Corporations Proprietary Technology for Alzheimer’s Disease Enters Stage 4 of 7 Stage ProcessHalberd Corporation's Proprietary Technology for Alzheimer’s Disease Enters Stage 4 of 7 Stage Process
finance.yahoo.com - June 21 at 9:42 AM
Halberd Corp.: Halberd Corporation Successfully Conjugates Metallic Particles and Antibodies Against Alzheimers Disease-Associated AntigensHalberd Corp.: Halberd Corporation Successfully Conjugates Metallic Particles and Antibodies Against Alzheimer's Disease-Associated Antigens
finanznachrichten.de - June 18 at 12:38 AM
Halberd Corporation Successfully Conjugates Metallic Particles and Antibodies Against Alzheimers Disease-Associated AntigensHalberd Corporation Successfully Conjugates Metallic Particles and Antibodies Against Alzheimer's Disease-Associated Antigens
finance.yahoo.com - June 16 at 1:01 PM
Halberd Corp.: Halberd Corporation Undertakes Process Toward the Elimination of Alzheimers DiseaseHalberd Corp.: Halberd Corporation Undertakes Process Toward the Elimination of Alzheimer's Disease
finanznachrichten.de - June 10 at 10:25 PM
Halberd Corporation Undertakes Process Toward the Elimination of Alzheimer’s DiseaseHalberd Corporation Undertakes Process Toward the Elimination of Alzheimer’s Disease
finance.yahoo.com - June 9 at 11:08 AM
Halberd Corporation: Halberd Corp. Files Provisional Patent Application Complementing Patented Extracorporeal Radio Frequency/Laser ProjectsHalberd Corporation: Halberd Corp. Files Provisional Patent Application Complementing Patented Extracorporeal Radio Frequency/Laser Projects
finanznachrichten.de - June 3 at 6:44 PM
Halberd Corp. Files Provisional Patent Application Complementing Patented Extracorporeal Radio Frequency/Laser ProjectsHalberd Corp. Files Provisional Patent Application Complementing Patented Extracorporeal Radio Frequency/Laser Projects
finance.yahoo.com - June 1 at 8:49 AM
Halberd Corporation Successfully Conjugates Metallic Particles and E. Coli AntibodyHalberd Corporation Successfully Conjugates Metallic Particles and E. Coli Antibody
finance.yahoo.com - May 25 at 12:30 PM
"MarketWatch" Features Halberd Corporation With Prominent Pharmaceutical Companies on New Treatments for COVID-19"MarketWatch" Features Halberd Corporation With Prominent Pharmaceutical Companies on New Treatments for COVID-19
finance.yahoo.com - May 19 at 1:19 PM
New Approaches to Covid-19 Treatment Enter the PictureNew Approaches to Covid-19 Treatment Enter the Picture
marketwatch.com - May 13 at 10:54 PM
Halberd Corporation Begins Testing of Patented Process for Laser Eradication of DiseaseHalberd Corporation Begins Testing of Patented Process for Laser Eradication of Disease
finance.yahoo.com - May 13 at 11:36 AM
Halberd Corporation: Halberd Corp. Designated as a BREAKOUT Stock to Watch in Investor PublicationsHalberd Corporation: Halberd Corp. Designated as a BREAKOUT Stock to Watch in Investor Publications
finanznachrichten.de - May 10 at 8:40 AM
Halberd Corp. Designated as a BREAKOUT Stock to Watch in Investor PublicationsHalberd Corp. Designated as a BREAKOUT Stock to Watch in Investor Publications
finance.yahoo.com - May 10 at 8:40 AM
Halberd Corporation Appoints New Chief Technical Officer to Optimize Upcoming Experiments On Radio Frequency and Laser Eradication of DiseaseHalberd Corporation Appoints New Chief Technical Officer to Optimize Upcoming Experiments On Radio Frequency and Laser Eradication of Disease
finance.yahoo.com - May 4 at 12:45 PM
Halberd Corporation Moves Radio Frequency (RF) Disease Elimination Effort Forward with the Addition of Youngstown State University (YSU) and Dr. William G. SturrusHalberd Corporation Moves Radio Frequency (RF) Disease Elimination Effort Forward with the Addition of Youngstown State University (YSU) and Dr. William G. Sturrus
finance.yahoo.com - April 19 at 9:23 AM
Epidemiologic Solutions Corporation (ESC), an IRS Approved, Qualified Public Charity, Announces Its Funding for Its "Pain-Free-Veterans" InitiativeEpidemiologic Solutions Corporation (ESC), an IRS Approved, Qualified Public Charity, Announces Its Funding for Its "Pain-Free-Veterans" Initiative
finance.yahoo.com - April 14 at 11:09 AM
Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application on Covid-19 Inflammatory Cytokine Storm TreatmentHalberd Corporation Files International Patent Cooperation Treaty (PCT) Application on Covid-19 Inflammatory Cytokine Storm Treatment
finance.yahoo.com - April 12 at 1:01 PM
Halberd Corporation CEO LetterHalberd Corporation CEO Letter
finance.yahoo.com - April 6 at 12:39 PM
Halberd Corporations Scientific Breakthrough: Conjugating Metallic Particles to SARS-CoV-2 and E. Coli AntigensHalberd Corporation's Scientific Breakthrough: Conjugating Metallic Particles to SARS-CoV-2 and E. Coli Antigens
finance.yahoo.com - March 30 at 8:59 AM
Halberd Corporation Completes Compilation of Medical Articles in Support of Nutraceuticals in Their VITA-SHIELD-MAX Immune BoosterHalberd Corporation Completes Compilation of Medical Articles in Support of Nutraceuticals in Their VITA-SHIELD-MAX Immune Booster
finanznachrichten.de - March 25 at 10:23 AM
Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application Covering Extracorporeal TreatmentHalberd Corporation Files International Patent Cooperation Treaty (PCT) Application Covering Extracorporeal Treatment
bloomberg.com - March 20 at 9:54 AM
Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application Covering Extracorporeal Treatment of COVID-19 and Other Medical MaladiesHalberd Corporation Files International Patent Cooperation Treaty (PCT) Application Covering Extracorporeal Treatment of COVID-19 and Other Medical Maladies
finance.yahoo.com - March 18 at 12:27 PM
Halberd Corporation Starts VITA-SHIELD-MAX Immunity Boosting Nutraceutical ProductionHalberd Corporation Starts VITA-SHIELD-MAX Immunity Boosting Nutraceutical Production
finanznachrichten.de - March 16 at 9:07 AM
Halberd Corporation Starts VITA-SHIELD-MAX(TM) Immunity Boosting Nutraceutical ProductionHalberd Corporation Starts VITA-SHIELD-MAX(TM) Immunity Boosting Nutraceutical Production
finance.yahoo.com - March 16 at 9:07 AM
Halberd Corporation Files VITA-SHIELD-MAX Trademark for Immunity Boosting NutraceuticalHalberd Corporation Files VITA-SHIELD-MAX Trademark for Immunity Boosting Nutraceutical
finanznachrichten.de - March 11 at 8:48 AM
Halberd Corporation Files VITA-SHIELD-MAX(TM) Trademark for Immunity Boosting NutraceuticalHalberd Corporation Files VITA-SHIELD-MAX(TM) Trademark for Immunity Boosting Nutraceutical
finance.yahoo.com - March 11 at 8:48 AM
Halberd Corporations CEO Interviewed on "The Stock Day Podcast" - Focus on Halberds New 20x Affinity Neutralizing SAHalberd Corporation's CEO Interviewed on "The Stock Day Podcast" - Focus on Halberd's New 20x Affinity Neutralizing SA
bloomberg.com - March 9 at 2:31 PM
Halberd Corporations CEO Interviewed on "The Stock Day Podcast" - Focus on Halberds New 20x Affinity Neutralizing SARS-COV-2 AntibodyHalberd Corporation's CEO Interviewed on "The Stock Day Podcast" - Focus on Halberd's New 20x Affinity Neutralizing SARS-COV-2 Antibody
finance.yahoo.com - March 9 at 9:31 AM
Halberds CEO on The Stock Day Podcast Breaking Down 20X Neutralizing Affinity SARS-COV-2 AntibodyHalberd's CEO on The Stock Day Podcast Breaking Down 20X Neutralizing Affinity SARS-COV-2 Antibody
finance.yahoo.com - March 9 at 9:31 AM
Epidemiologic Solutions Corporation (ESC), an IRS Approved, Qualified Public Charity, Announces Its Commitment of $2,000,000 to Halberd Corporation Research Endeavors (HALB), as Its Initial Step Toward Eradicating DiseaseEpidemiologic Solutions Corporation (ESC), an IRS Approved, Qualified Public Charity, Announces Its Commitment of $2,000,000 to Halberd Corporation Research Endeavors (HALB), as Its Initial Step Toward Eradicating Disease
finance.yahoo.com - March 8 at 8:10 AM
This Week on MoneyTV with Donald Baillargeon, 3/5This Week on MoneyTV with Donald Baillargeon, 3/5
finance.yahoo.com - March 5 at 7:30 AM
Halberds 2nd Proprietary Antibody Against SARS-COV-2 Spike Protein Demonstrates Neutralizing Affinity 20 Times GreateHalberd's 2nd Proprietary Antibody Against SARS-COV-2 Spike Protein Demonstrates Neutralizing Affinity 20 Times Greate
bloomberg.com - March 3 at 8:09 AM
Halberd Collaborates with GreenBioAZ, Inc. for the Development of its Patent Pending Radio Frequency Technology to Eliminate Disease PathogensHalberd Collaborates with GreenBioAZ, Inc. for the Development of its Patent Pending Radio Frequency Technology to Eliminate Disease Pathogens
finance.yahoo.com - February 16 at 1:01 PM
Halberd Corporations CEO Interviewed on The Stock Day Podcast and on MoneyTVHalberd Corporation's CEO Interviewed on The Stock Day Podcast and on MoneyTV
finance.yahoo.com - February 1 at 9:38 AM
Halberd Corporation Discusses Qualitative and Quantitative Diagnostic Methodology for Detecting COVID-19 Antibodies and Antigens with The Stock Day PodcastHalberd Corporation Discusses Qualitative and Quantitative Diagnostic Methodology for Detecting COVID-19 Antibodies and Antigens with The Stock Day Podcast
finance.yahoo.com - January 28 at 1:44 PM
Halberd Corporation’s Research Breakthrough - Qualitative & Quantitative Measurement of Covid-19 Antigens and/or AntibodiesHalberd Corporation’s Research Breakthrough - Qualitative & Quantitative Measurement of Covid-19 Antigens and/or Antibodies
finance.yahoo.com - January 25 at 12:46 PM
Halberd Corp. Develops Medication to Boost Immune System Against SARS-CoV-2 (Covid-19)Halberd Corp. Develops Medication to Boost Immune System Against SARS-CoV-2 (Covid-19)
finance.yahoo.com - January 14 at 7:51 PM
Halberd Corporation’s Covid-19 Efforts Recognized in Wall Street PR News ArticleHalberd Corporation’s Covid-19 Efforts Recognized in Wall Street PR News Article
finance.yahoo.com - January 12 at 9:01 AM
Halberd Corporation 2020 Year End CEO LetterHalberd Corporation 2020 Year End CEO Letter
finance.yahoo.com - January 4 at 12:23 PM
Halberd Corporation Produces a Second Monoclonal Antibody Against Covid-19 Spike ProteinHalberd Corporation Produces a Second Monoclonal Antibody Against Covid-19 Spike Protein
finance.yahoo.com - December 23 at 11:04 AM
Halberd Corporation Pursues Extracorporeal Radio Frequency Treatment Against Covid-19Halberd Corporation Pursues Extracorporeal Radio Frequency Treatment Against Covid-19
finance.yahoo.com - December 17 at 1:12 PM
Halberd Corp. Research Yields Potent SARS-CoV-2 AntibodyHalberd Corp. Research Yields Potent SARS-CoV-2 Antibody
finance.yahoo.com - December 14 at 8:02 AM
Halberd Corporation Discusses Positive Antibody Test Results Against COVID-19 with The Stock Day PodcastHalberd Corporation Discusses Positive Antibody Test Results Against COVID-19 with The Stock Day Podcast
finance.yahoo.com - December 10 at 11:28 AM
Halberd Corp. Research Yields Promising SARS-CoV-2 Antibody in Laboratory TestingHalberd Corp. Research Yields Promising SARS-CoV-2 Antibody in Laboratory Testing
finance.yahoo.com - December 7 at 6:18 PM
Halberd Corporations Covid-19 Technology Recognized by Momentum ObserverHalberd Corporation's Covid-19 Technology Recognized by Momentum Observer
finance.yahoo.com - December 2 at 5:43 PM
Halberd Corporation Advisory Board Reorganization AnnouncedHalberd Corporation Advisory Board Reorganization Announced
finance.yahoo.com - December 1 at 3:57 PM
Halberd Corp. CEO Interviewed on Money TV; Discusses 2020 Accomplishments and PlansHalberd Corp. CEO Interviewed on Money TV; Discusses 2020 Accomplishments and Plans
finance.yahoo.com - November 25 at 12:40 PM
This Week on MoneyTV with Donald Baillargeon, 11/25This Week on MoneyTV with Donald Baillargeon, 11/25
finance.yahoo.com - November 25 at 7:39 AM
Halberd Corporation Files for Patent Protection on Covid-19 Extracorporeal Treatment VariationHalberd Corporation Files for Patent Protection on Covid-19 Extracorporeal Treatment Variation
finance.yahoo.com - November 19 at 12:45 PM
Halberd Corp. CEO Interviewed on Money TV; Discusses New Fluorescent Covid-19 AntibodyHalberd Corp. CEO Interviewed on Money TV; Discusses New Fluorescent Covid-19 Antibody
finance.yahoo.com - November 16 at 11:19 AM
This page was last updated on 6/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.